Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1674
| Despition | KCNIP3 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 90.0% (SDS-PAGE) |
| Form | Sterile Filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1423 | Human ALDH5A1 Protein (AC1423) | 2 µg | inquiry |
| ACPP-1505 | Human CRYGD Protein (AC1505) | 5 µg | inquiry |
| ACPP-1764 | Human ANTXR2 Protein (AC1764) | 2 µg | inquiry |
| ACPP-1244 | SOX2 Blocking Peptide (AC1244) | 250 µg | inquiry |
| ACPP-1744 | Human C1q Protein (AC1744) | 200 µg | inquiry |
| ACPP-1672 | Human SERPINA3 Protein (AC1672) | 20 µg | inquiry |
| ACPP-1461 | Human Luteinizing Hormone Protein (AC1461) | 100 µg | inquiry |
| ACPP-1285 | Niemann Pick C1 Blocking Peptide (AC1285) | 250 µg | inquiry |
| ACPP-1671 | Human SPINT2 Protein, Sf9 (AC1671) | 2 µg | inquiry |
| ACPP-1796 | Human GAP43 Protein (AC1796) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.